Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease. [electronic resource]
Producer: 20150414Description: 1400-19 p. digitalISSN:- 1520-4804
- Animals
- Cell Survival -- drug effects
- Cells, Cultured
- Dose-Response Relationship, Drug
- Humans
- Mice
- Molecular Structure
- Monoamine Oxidase -- metabolism
- Monoamine Oxidase Inhibitors -- chemical synthesis
- Neuroprotective Agents -- chemical synthesis
- PC12 Cells
- Pargyline -- analogs & derivatives
- Parkinson Disease -- drug therapy
- Propylamines -- chemical synthesis
- Rats
- Structure-Activity Relationship
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.